Eric W. Hoffman

8.3k citations

62 papers · 2.5k indexed · h-index 26

Impact in

Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in ⓘ

Immunology 24
- Immunotherapy and Immune Responses 23
- T-cell and B-cell Immunology 9
Biotechnology 8
- Cancer Research and Treatments 8

Co-authors: Lloyd J. Old (32 shared papers)Gerd Ritter (11 shared papers)Sacha Gnjatic (8 shared papers)Linda Pan (9 shared papers)Elke Jäger (6 shared papers)Antje Neumann (6 shared papers)Julia Karbach (6 shared papers)Alexander Knuth (5 shared papers)
Journals: Journal of Clinical Oncology (15 papers)International Journal of Cancer (4 papers)Proceedings of the National Academy of Sciences (4 papers)Clinical Cancer Research (3 papers)Health Communication (2 papers)
Partner nations: United States Australia Germany

In The Last Decade

Eric W. Hoffman

59 papers receiving 2.5k citations

Peers

Countries citing papers authored by Eric W. Hoffman

Since Specialization

Citations

This map shows the geographic impact of Eric W. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric W. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric W. Hoffman more than expected).

Fields of papers citing papers by Eric W. Hoffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric W. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric W. Hoffman. The network helps show where Eric W. Hoffman may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric W. Hoffman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric W. Hoffman Line = papers co-authored together Eric W. Hoffman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers Proceedings of the National Academy of Sciences ·Elke Jäger, Sacha Gnjatic, Yasuhiro Nagata, Elisabeth Stockert, Dirk Jäger, Julia Karbach, Antje Neumann, Julia Rieckenberg, Yao‐Tseng Chen, Gerd Ritter, Eric W. Hoffman, Michael Arand, Lloyd J. Old, Alexander Knuth	2000	363
2	Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer Proceedings of the National Academy of Sciences ·Kunle Odunsi, Feng Qian, Junko Matsuzaki, Paulette Mhawech‐Fauceglia, Chris Andrews, Eric W. Hoffman, Linda Pan, Gerd Ritter, Jeannine Villella, Bridget V. Thomas, Kerry J. Rodabaugh, Shashikant Lele, Protul Shrikant, Lloyd J. Old, Sacha Gnjatic	2007	213
3	Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients Proceedings of the National Academy of Sciences ·Elke Jäger, Julia Karbach, Sacha Gnjatic, Antje Neumann, Armin Bender, Danila Valmori, Maha Ayyoub, Erika Ritter, Gerd Ritter, Dirk Jäger, Dennis Panicali, Eric W. Hoffman, Linda Pan, Herbert F. Oettgen, Lloyd J. Old, Alexander Knuth	2006	172
4	Vaccine-Induced CD4+ T Cell Responses to MAGE-3 Protein in Lung Cancer Patients The Journal of Immunology ·Djordje Atanackovic, Nasser K. Altorki, Elisabeth Stockert, Barbara Williamson, Achim A. Jungbluth, Erika Ritter, Darren Santiago, Cathy A. Ferrara, Mitsutoshi Matsuo, Annamalai Selvakumar, Bo Dupont, Yao-Tseng Chen, Eric W. Hoffman, Gerd Ritter, Lloyd J. Old, Sacha Gnjatic	2004	148
5	Filgrastim in Patients with Chemotherapy-Induced Febrile Neutropenia: A Double-Blind, Placebo-Controlled Trial Annals of Internal Medicine ·Dermot Maher, Graham J. Lieschke, (unknown), (unknown), (unknown), M Wolf, William Sheridan, Richard Kefford, Jonathan Cebon, Ian Olver, (unknown), Guy C. Toner, (unknown), Marian Lieschke, Scott Cruickshank, (unknown), Eric W. Hoffman, (unknown), George Morstyn	1994	129
6	Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma Investigational New Drugs ·Patrick A. Ott, Richard D. Carvajal, Neeta Pandit‐Taskar, Achim A. Jungbluth, Eric W. Hoffman, Bor-Wen Wu, John S. Bomalaski, Ralph Venhaus, Linda Pan, Lloyd J. Old, Anna C. Pavlick, Jedd D. Wolchok	2012	121
7	Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming Proceedings of the National Academy of Sciences ·Djordje Atanackovic, Nasser K. Altorki, Yanran Cao, Erika Ritter, Cathy A. Ferrara, Gerd Ritter, Eric W. Hoffman, Carsten Bokemeyer, Lloyd J. Old, Sacha Gnjatic	2008	119
8	HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan Clinical Cancer Research ·Shigehisa Kitano, Shinichi Kageyama, Yasuhiro Nagata, Yoshihiro Miyahara, Atsunori Hiasa, Hiroaki Naota, Satoshi Okumura, Hiroshi Imai, Taizo Shiraishi, Masahiro Masuya, Masakatsu Nishikawa, Junzo Sunamoto, Kazunari Akiyoshi, Takashi Kanematsu, Andrew M. Scott, Roger Murphy, Eric W. Hoffman, Lloyd J. Old, Hiroshi Shiku	2006	103
9	Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma Clinical Cancer Research ·Theo Nicholaou, Lisa M. Ebert, Ian D. Davis, Grant A. McArthur, Heather Jackson, Nektaria Dimopoulos, Bee Shin Tan, Eugene Maraskovsky, Lena Miloradovic, Wendie Hopkins, Linda Pan, Ralph Venhaus, Eric W. Hoffman, Weisan Chen, Jonathan Cebon	2009	100
10	Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel Cancer Science ·Shinichi Kageyama, Shigehisa Kitano, Michiko Hirayama, Yasuhiro Nagata, Hiroshi Imai, Taizo Shiraishi, Kazunari Akiyoshi, Andrew M. Scott, Roger Murphy, Eric W. Hoffman, Lloyd J. Old, Naoyuki Katayama, Hiroshi Shiku	2008	95
11	Exploring College Students’ Use of General and Alcohol-Related Social Media and Their Associations With Alcohol-Related Behaviors Journal of American College Health ·Eric W. Hoffman, Bruce E. Pinkleton, Erica Weintraub Austin, Wanda Reyes-Velázquez	2014	83
12	Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence International Journal of Cancer ·C. Smith, P. Rod Dunbar, Fareed Mirza, Michael J. Palmowski, Dawn Shepherd, Sarah C. Gilbert, Pierre G. Coulie, J Schneider, Eric W. Hoffman, Robert D. Hawkins, Adrian L. Harris, Vincenzo Cerundolo	2004	72
13	A phase I study of vaccination with NY‐ESO‐1f peptide mixed with Picibanil OK‐432 and Montanide ISA‐51 in patients with cancers expressing the NY‐ESO‐1 antigen International Journal of Cancer ·Kazuhiro Kakimi, Midori Isobe, Akiko Uenaka, Hisashi Wada, Eiichi Sato, Yuichiro� Doki, Jun Nakajima, Yasuyuki Seto, Tomoki Yamatsuji, Yoshio Naomoto, Kenshiro Shiraishi, Nagio Takigawa, Katsuyuki Kiura, Kazuhide Tsuji, Keiji Iwatsuki, Mikio Oka, Linda Pan, Eric W. Hoffman, Lloyd J. Old, Eiichi Nakayama	2011	66
14	Phase I clinical trial with fractionated radioimmunotherapy using 131I-labeled chimeric G250 in metastatic renal cancer. PubMed ·Chaitanya Divgi, Joseph A. O’Donoghue, Sydney Welt, Jayne O'Neel, Ron Finn, Robert J. Motzer, Achim A. Jungbluth, Eric W. Hoffman, Gerd Ritter, Steven M. Larson, Lloyd J. Old	2004	66
15	Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma. PubMed ·Jonathan Cebon, Elke Jäger, Mark Shackleton, Peter Gibbs, Ian D. Davis, Wendie Hopkins, Sharen Gibbs, Qiyuan Chen, Julia Karbach, Heather Jackson, Duncan MacGregor, Sue Sturrock, Hilary Vaughan, Eugene Maraskovsky, Antje Neumann, Eric W. Hoffman, Mathew L Sherman, Alexander Knuth	2003	64
16	Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients International Journal of Cancer ·Ryohei Kawabata, Hisashi Wada, Midori Isobe, Takashi Saika, Shuichiro Sato, Akiko Uenaka, Hiroshi Miyata, Takushi Yasuda, Yuichiro� Doki, Yuji Noguchi, Hiromi Kumon, Kazuhide Tsuji, Keiji Iwatsuki, Hiroshi Shiku, Gerd Ritter, Roger Murphy, Eric W. Hoffman, Lloyd J. Old, Morito Monden, Eiichi Nakayama	2007	58
17	A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen Clinical Cancer Research ·Andrew M. Scott, Niall C. Tebbutt, Fook-Thean Lee, T. Cavicchiolo, Zhanqi Liu, Sanjeev Gill, Aurora Poon, Wendie Hopkins, Fiona E. Smyth, Carmel Murone, Duncan MacGregor, Anthony T. Papenfuss, Bridget Chappell, Timothy Saunder, Martin W. Brechbiel, Ian D. Davis, Roger Murphy, Geoffrey Chong, Eric W. Hoffman, Lloyd J. Old	2007	55
18	LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer. PubMed ·Armin Bender, Julia Karbach, Antje Neumann, Dirk Jäger, S. Al-Batran, Akin Atmaca, Eckhart Weidmann, Melina Biskamp, Sacha Gnjatic, Linda Pan, Eric W. Hoffman, Lloyd J. Old, Alexander Knuth, Elke Jäger	2007	47
19	An Exploration of the Associations of Alcohol-Related Social Media Use and Message Interpretation Outcomes to Problem Drinking Among College Students Health Communication ·Eric W. Hoffman, Erica Weintraub Austin, Bruce E. Pinkleton, Bruce Austin	2016	41
20	A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma. PubMed ·Ian D. Davis, Gregory A. Wiseman, Fook-Thean Lee, Denise N. Gansen, Wendie Hopkins, Anthony T. Papenfuss, Zhanqi Liu, Timothy J. Moynihan, Gary A. Croghan, Alex A. Adjei, Eric W. Hoffman, James N. Ingle, Lloyd J. Old, Andrew M. Scott	2007	40

About Eric W. Hoffman

Eric W. Hoffman is a scholar working on Immunology, Biotechnology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology, having authored 62 papers that have together received 2.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (23 papers), vaccines and immunoinformatics approaches (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (10 papers), T-cell and B-cell Immunology (9 papers), Cancer Research and Treatments (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Renal cell carcinoma treatment (5 papers). The work is most often cited by research in Immunology (1.5k citations), Oncology (965 citations), Biotechnology (156 citations), Molecular Biology (995 citations) and Radiology, Nuclear Medicine and Imaging (315 citations). Eric W. Hoffman has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Lloyd J. Old, Gerd Ritter, Sacha Gnjatic, Linda Pan, Elke Jäger, Antje Neumann, Julia Karbach, Alexander Knuth, Yasuhiro Nagata and Elisabeth Stockert. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Cancer, Proceedings of the National Academy of Sciences, Clinical Cancer Research and Health Communication.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact